"Designing Growth Strategies is in our DNA"

Tuberculosis (TB) Diagnostics Market Size, Share & Industry Analysis, By Type (Culture-based Diagnostics, Sputum Smear Microscopy, Rapid Molecular Diagnostics, and Others), By Disease Site (Pulmonary Tuberculosis and Extrapulmonary Tuberculosis), By End-user (Diagnostic & Reference Laboratories, Hospitals, Academic & Research Institutes, and Others), and Regional Forecast, 2026-2034

Last Updated: September 07, 2026 | Format: PDF | Report ID: FBI102009

 


To get information on various segments, share your queries with us

ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year  2026
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 6.3% from 2026-2034
Unit Value (USD Billion)
Segmentation By Type, Disease Site, End-user, and Region
By Type
  • Culture-based Diagnostics
  • Sputum Smear Microscopy
  • Rapid Molecular Diagnostics
  • Others
By Disease Site
  • Pulmonary Tuberculosis
  • Extrapulmonary Tuberculosis
By End-user
  • Diagnostic & Reference Laboratories
  • Hospitals 
  • Academic & Research Institutes
  • Others
By Region
  • North America (By Type, Disease Site, End-user, and Country)
    • U.S. 
    • Canada
  • Europe (By Type, Disease Site, End-user, and Country)
    • U.K.
    • Germany 
    • France 
    • Italy 
    • Russia
    • Nordic
    • Rest of Europe
  • Asia Pacific (By Type, Disease Site, End-user, and Country)
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Type, Disease Site, End-user, and Country)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Disease Site, End-user, and Country)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

 

  • 2021-2034
  • 2025
  • 2021-2024
  • 121
Download Free Sample

    man icon
    Mail icon
    Mail icon

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann